Brixadi and Sublocade are both long-acting buprenorphine injections for opioid use disorder. Both replace daily films or tablets with a shot given in a medical office, and both are given just under the skin. They differ in how often you get them, how you can start and where on the body they are given.
How often
- Sublocade: once a month.
- Brixadi: once a week or once a month, depending on which form your provider chooses.
How you start
Sublocade is started only after you have taken sublingual buprenorphine and shown you tolerate it. Depending on current FDA labeling and your history, that can be a single test dose with a short observation period or several days of stable daily dosing.
Brixadi comes in two forms. The FDA describes the weekly injection as usable in people who have started treatment with a single dose of buprenorphine, and the monthly version as for people already being treated with buprenorphine.
Where the shot goes
- Sublocade: under the skin at an approved site, such as the abdomen. It forms a small lump that may be noticeable for several weeks and slowly shrinks; do not rub or massage it.
- Brixadi: under the skin of the buttock, thigh, stomach (abdomen) or upper arm. It turns into a gel called a depot, which is not always felt; do not try to remove it.
What they have in common
- Neither is ever taken home. Both are given only by a healthcare provider in a healthcare setting, because injecting them into a vein can cause serious harm or death.
- Both contain buprenorphine, so the same safety rules apply. Because buprenorphine only partly activates opioid receptors, it has a ceiling on its effect on breathing and is safer than full opioids. It can still cause dangerous or fatal breathing problems when combined with alcohol, benzodiazepines or other sedatives, or when taken by someone who does not use opioids, including children. Store it locked up and keep naloxone at home.
- If you miss a dose of either, call your provider to get your injection as soon as possible, and do not try to make up for it with other opioids.
Ready to Start Treatment?
Confidential, evidence-based care in West Ashley. Call to ask about the next available new-patient appointment.
5 cards. Swipe or tap to see the next one.
Which one fits you?
There is no single right answer. A weekly shot means more visits, which some people prefer early in treatment. A monthly shot means fewer trips to the office. Your history, how you have done on buprenorphine so far and your insurance all play a part. South Carolina Medicaid and most commercial plans generally cover these medicines, but prior authorization and plan rules vary, and we are not in network with Select Health (First Choice). We verify your coverage before treatment.
Read more about Brixadi and Sublocade at our West Ashley office, or about transferring your care if you already get one of these shots elsewhere.
Sources: FDA, FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder (May 23, 2023); Brixadi Medication Guide (DailyMed); Sublocade prescribing information.
Help at Hope Addiction Medicine
Our team combines medication with counseling and behavioral therapies, through hybrid in-person and virtual care from our West Ashley office in Charleston, with urine drug screens at a local lab and periodic vitals checks close to home. Call to ask about the next available new-patient appointment. Request an appointment or call our office.
This article is general information, not medical advice, and does not create a patient–provider relationship. Every situation is different, so see a provider who can evaluate yours and develop a plan of care. Any medication discussed here may not be right for you: the right choice depends on your diagnoses, other health conditions and current medicines, so take medication only as directed by the provider managing your care. If you are ever in doubt about an emergency, call 911 or go to the nearest emergency room. If someone may be overdosing, call 911 and give naloxone if you have it.
Frequently Asked Questions
Sublocade is given once a month. Brixadi comes as a weekly or a monthly injection. They also differ in how you start and where on the body the shot is given.
The FDA describes the weekly Brixadi injection as usable in people who have started treatment with a single dose of buprenorphine. The monthly shot is intended for people who are already taking buprenorphine.
No. Both are given only by a healthcare provider in a healthcare setting, because injecting them into a vein can cause serious harm or death.